CHICAGO, Feb. 27 /PRNewswire-FirstCall/ -- Morningstar, Inc. (Nasdaq: MORN), a leading provider of independent investment research, is holding a conference call for institutional investors including portfolio managers at mutual funds, hedge funds, pensions, and endowments. The topic of the call is "The Top 15 Biotech Acquisition Targets" and it will be held at 11 a.m. EST, 10 a.m. CST on Wednesday, March 4.
Damien Conover, CFA, Morningstar's equity strategist for the healthcare sector and the Morningstar Healthcare Observer institutional newsletter, will share the results of analysis conducted by Morningstar's team of 12 healthcare analysts on the 63 biotech companies they cover. The team ranked each company by its likelihood of being acquired based upon a methodology that weighed drug portfolio strength, profit-boosting power, collaborative fit, financial health, and recent stock performance.
Conover will be joined on the call by biotech analyst Karen Andersen.
Institutional investors: To obtain dial-in instructions, please RSVP with your name and company name to Heather Brilliant, Morningstar's Director of Stock Analysis, at email@example.com.
Press registration: To obtain dial-in instructions, please RSVP to Courtney Goethals Dobrow at firstname.lastname@example.org.
About Morningstar, Inc.
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offers an extensive line of Internet, software, and print-based products and services for individuals, financial advisors, and institutions. Morningstar provides data on more than 300,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time pricing data on more than 4 million global equities, commodities, derivatives, indexes, and foreign currencies. The company has operations in 19 countries and minority ownership positions in companies based in three other countries.
(C)2009 Morningstar Inc. All rights reserved. Media Contact: Courtney Goethals Dobrow 312-696-6241, email@example.com
|SOURCE Morningstar, Inc.|
Copyright©2009 PR Newswire.
All rights reserved